skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

100+ Total results for product and free and sample content found

Trialtrove

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

01 Jul 2022

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

To highlight the growing importance of IO and especially IO combination trials within oncology clinical development, visual trends and key insights about the past 20+ years were compiled.

Pink Sheet

Trumps Drug Pricing Plan: The Headlines Are The Goal - But Also A Threat

By Michael McCaughan 16 Jun 2022

US Election Drug Pricing Reform

The latest flurry of Executive Order activity on drug pricing reinforces the message that the President wants to own the headlines for being tough on the drug industry as Election Day looms. Looking for substance beyond that goal is a fool’s errand – but the headlines could still have significant consequences no matter who wins in November.

Topic US Election 2020

Medtech Insight

US Election 2020: Almost All House Members Backed By Industry PAC Dollars Retain Seats

By Sue Darcey 16 Jun 2022

US Election 2020 PAC dollars

Out of 31 US House incumbents supported by high amounts of medtech industry political action committee (PAC) dollars, only one – Chrissy Houlahan of Pennsylvania – lost in last week’s election.

Topic US Election 2020 Policy & Regulation Legislation

Pink Sheet

China-US Relationship Hinges On Changing Internal, External Forces

By Brian Yang 16 Jun 2022

US Election China Relations

Given the ongoing election challenges in the US, China has yet to officially congratulate Joe Biden as the next US president, although many world leaders are already hailing a reset in US foreign policy. Many are wondering if this and other moves indicate a quiet internal shift for China's high tech and life sciences sectors, just days after Beijing concluded a high-level plenary meeting outlining its priorities for the next five years.

Topic US Election 2020 China

Pharma 360

Global Oncology Opportunities & Trends 2025: Key Markets, Indications and Product

13 May 2022

Pharma Intelligence

Join Informa Pharma Intelligence for the “Global Oncology Opportunities” webinar! 

Chemist + Druggist Data

New pip codes for Northern Ireland and Great Britain

11 Mar 2022

New pip codes for Northern Ireland and Great Britain

We are pleased to announce that from mid-February 2022, C+D Data will provide the UK supply chain with additional product listings and associated PIP-codes for Northern Ireland (NI) and Great Britain (GB.)  This solution will allow you to reach the entire UK market quickly and facilitate the ordering and distribution of medicines without disruption to you, and your wholesalers – while ensuring the data’s accuracy, visibility, and long-term management. 

Pink Sheet

Accelerated Approval Makes Big Splash In 2021 Novel Agents, Despite Crackdown On ‘Dangling’ Cancer Claims

By Bridget Silverman 19 Jan 2022

PS2201_PP_bigsplash_1200

US FDA’s accelerated approvals hit a contemporary high in 2021, accounting for one-third of novel US approvals, but the big story was the agency’s crackdown on delinquent confirmatory trials for oncology AA indications.

Generics Bulletin

Medicines For Ireland Appoints New Chairs Following Framework Agreement

By Chloe Kent 18 Jan 2022

GB2201_Ireland_flag_2DEP1CR_1200

Medicines for Ireland has appointed Accord Healthcare Ireland managing director Padraic O’Brien as chairperson and Teva Ireland director of generic products Paul Neill as vice chairperson of the Irish industry association. The changes come just a few weeks after Ireland implemented its new framework agreement on off-patent pricing.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: